Biomerica, Inc. (BMRA)
1.68
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
1.71
+0.03
(+1.79%)
After-Hours: 20:00
Biomerica Net Income (Quarterly) : -1.232M for Aug. 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2026 | -1.232M |
| May 31, 2026 | -1.145M |
| February 28, 2026 | -1.312M |
| November 30, 2025 | -1.32M |
| August 31, 2025 | 0.002M |
| May 31, 2025 | -1.544M |
| February 28, 2025 | -1.163M |
| November 30, 2024 | -0.95M |
| August 31, 2024 | -1.316M |
| May 31, 2024 | -1.421M |
| February 29, 2024 | -1.918M |
| November 30, 2023 | -1.507M |
| August 31, 2023 | -1.132M |
| May 31, 2023 | -1.792M |
| February 28, 2023 | -1.650M |
| November 30, 2022 | -1.626M |
| August 31, 2022 | -2.072M |
| May 31, 2022 | -1.759M |
| February 28, 2022 | -0.1042M |
| November 30, 2021 | -1.125M |
| August 31, 2021 | -1.543M |
| May 31, 2021 | -1.711M |
| February 28, 2021 | -2.124M |
| November 30, 2020 | -1.718M |
| August 31, 2020 | -1.892M |
| Date | Value |
|---|---|
| May 31, 2020 | -0.4866M |
| February 29, 2020 | -0.8609M |
| November 30, 2019 | -0.4853M |
| August 31, 2019 | -0.5063M |
| May 31, 2019 | -0.7853M |
| February 28, 2019 | -0.6787M |
| November 30, 2018 | -0.4772M |
| August 31, 2018 | -0.4517M |
| May 31, 2018 | -0.6676M |
| February 28, 2018 | -0.3225M |
| November 30, 2017 | -0.2687M |
| August 31, 2017 | -0.2071M |
| May 31, 2017 | -0.3458M |
| February 28, 2017 | -0.3041M |
| November 30, 2016 | -0.2029M |
| August 31, 2016 | -0.0554M |
| May 31, 2016 | -1.226M |
| February 29, 2016 | -0.135M |
| November 30, 2015 | -0.0668M |
| August 31, 2015 | -0.0723M |
| May 31, 2015 | 0.2431M |
| February 28, 2015 | -0.1172M |
| November 30, 2014 | -0.238M |
| August 31, 2014 | -0.2193M |
| May 31, 2014 | 0.1689M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 920.00M |
| Align Technology, Inc. | 108.29M |
| AngioDynamics, Inc. | -7.097M |
| Accuray, Inc. | -1.941M |
| Alphatec Holdings, Inc. | -25.78M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.265M |
| Total Expenses (Quarterly) | 2.497M |
| EPS Diluted (Quarterly) | -0.3738 |
| Enterprise Value | 7.319M |
| Gross Profit Margin (Quarterly) | 8.14% |
| Profit Margin (Quarterly) | -97.39% |
| Earnings Yield | -97.40% |
| Normalized Earnings Yield | -101.95 |